v3.25.2
Condensed Consolidated Statements of Operations, Unaudited - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Costs and Expenses        
Operating expenses 1,892,000 201,000 11,404,000 527,000
Research and development expenses 104,000 48,000 151,000 95,000
Loss from operations (1,996,000) (249,000) (11,555,000) (622,000)
Other income (expense)        
Gain on partial forgiveness of PPP note payable 0 0 0 0
Interest and financing expense (143,000) (84,000) (258,000) (160,000)
Net Loss $ (2,139,000) $ (333,000) $ (11,813,000) $ (782,000)
Net loss per common share, basic $ (0.00) $ (0.00) $ (0.03) $ (0.00)
Net loss per common share, diluted $ (0.00) $ (0.00) $ (0.03) $ (0.00)
Weighted average common shares outstanding, basic 495,547,582 398,506,532 467,026,067 395,939,821
Weighted average common shares outstanding, diluted 495,547,582 398,506,532 467,026,067 395,939,821

Source